[Use of cost-effectiveness analysis to guide the clinical implementation of new therapies].
Borrás Pérez
Francesc X
FX
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005252:Fees, Pharmaceutical; D006801:Humans